GSK2330672
200185
Phase 2 small_molecule completed
Quick answer
GSK2330672 for Diabetes Mellitus, Type 2 is a Phase 2 program (small_molecule) at ELITE PHARMACEUTICALS INC /NV/ with 1 ClinicalTrials.gov record(s).
Program details
- Company
- ELITE PHARMACEUTICALS INC /NV/
- Indication
- Diabetes Mellitus, Type 2
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed